The Observatory. Molecular Diagnostics.

The article reports on a white paper from the Association for Molecular Pathology that addresses the consequences of regulatory and reimbursement forces directed against molecular diagnostic testing. Topics include the threat posed by government regulations to the breakthroughs made by mapping of the human genome, and the U.S. Food and Drug Administration's policies that will reformulate existing medical device regulations.